文献速递产检与胎儿影像

阴道米索前列醇对比阴道地诺前列酮用于引产的系统综述与Meta分析

Vaginal Misoprostol Compared to Vaginal Dinoprostone for Induction of Labour: A Systematic Review and Meta‐Analysis
RSS 订阅 · BJOG · 2026-08-19

该系统综述与Meta分析纳入44篇随机对照试验,共7040例使用阴道米索前列醇和6604例使用阴道地诺前列酮的单胎足月引产孕妇。结果显示,阴道米索前列醇组24小时内阴道分娩比例更高,缩宫素使用更少,分娩时间更短。两组剖宫产率及母儿不良结局相似,25μg剂量组子宫过度刺激伴胎心率改变发生率更低。

要点

  • 阴道米索前列醇较阴道地诺前列酮更易在24小时内实现阴道分娩。
  • 米索前列醇组缩宫素使用更少,分娩时间约缩短230分钟。
  • 25μg米索前列醇子宫过度刺激伴胎心率改变发生率更低。

核心结论

  • 阴道米索前列醇相比阴道地诺前列酮,更可能实现24小时内阴道分娩,且未增加剖宫产,不良反应特征相似。

研究设计与样本

  • 系统综述与Meta分析,检索电子数据库中的随机对照试验,比较单胎足月引产中使用阴道地诺前列酮或阴道米索前列醇。
  • 采用随机效应模型进行Meta分析,使用Cochrane Risk of Bias 2工具评估偏倚风险。
  • 计划按米索前列醇剂量(25μg和≥50μg)进行亚组分析。

主要发现

  • 44篇论文报告7040例使用阴道米索前列醇、6604例使用阴道地诺前列酮的参与者。
  • 阴道米索前列醇组24小时内阴道分娩的优势比为1.48(95%CI 1.20-1.84),异质性高。
  • 阴道米索前列醇组较少需要缩宫素(OR 0.51,95%CI 0.40-0.65)。
  • 阴道米索前列醇组分娩时间缩短230分钟(95%CI -286至-175,I² 57.6%)。
  • 两组剖宫产率及母儿不良结局发生率相当。

关键数值与推荐

  • 24小时内阴道分娩:OR 1.48(95%CI 1.20-1.84)。
  • 缩宫素使用:OR 0.51(95%CI 0.40-0.65)。
  • 分娩时间缩短:-230分钟(95%CI -286至-175,I² 57.6%)。
  • 25μg剂量组子宫过度刺激伴胎心率改变发生率降低。

临床怎么用

  • 该信息可用于支持围绕引产药物选择的临床讨论。
  • 低剂量(25μg)米索前列醇可能同样有效,且子宫过度刺激发生率更低。

局限性

  • 24小时内阴道分娩结局的异质性高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Introduction Induction of labour is a common intervention. The prostaglandin dinoprostone is often used, but there is increasing evidence that misoprostol may be more effective without compromising safety. This review compares the efficacy and safety of vaginal misoprostol and vaginal dinoprostone. Methods Electronic databases were searched for randomised controlled trials comparing singleton, term inductions with vaginal dinoprostone or vaginal misoprostol. The primary outcome was vaginal births within 24 h. Secondary outcomes included induction to birth interval, mode of birth, oxytocin augmentation, uterine hyperstimulation, fetal distress and adverse maternal and neonatal outcomes. A sub-group analysis by misoprostol dosage (25 and ≥ 50 μg) was planned. A random effects meta-analysis was performed and risk of bias assessed using Cochrane Risk of Bias 2 tool. Results 44 papers reported 7040 participants induced with vaginal misoprostol and 6604 with vaginal dinoprostone. Participants given vaginal misoprostol were 48% (OR 1.48 95% CI 1.20, 1.84) more likely to achieve vaginal birth within 24 h, although heterogeneity was high. The rates of caesarean section, and adverse maternal or neonatal outcomes were comparable. In the vaginal misoprostol group, fewer patients required oxytocin (OR 0.51 95% CI 0.40, 0.65) and time to birth was reduced (−230 min (95% CI −286 to −175, I 2 57.6%)). These findings were consistent in the subgroup analysis, although uterine hyperstimulation with fetal heart rate changes was reduced in the 25-μg group. Conclusion Vaginal misoprostol is more effective for achieving vaginal birth in 24 h, reducing time to birth and oxytocin use when compared to vaginal dinoprostone. It does not seem to increase caesarean birth and has a similar side-effect profile. At lower doses (25-μg), it is likely to be similarly effective with a lower incidence of uterine hyperstimulation. This information can be used to support discussions around choice of induction agent.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. BJOG:Vaginal Misoprostol Compared to Vaginal Dinoprostone for Induction of Labour: A Systematic Review and Meta‐Analysis

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。